reviewNature reviews. CancerJun 18, 2009Closed access

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3

Vall d'Hebron Institut de Recerca · Hebron University · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,133
total citations
FWCI
42.92
Percentile
100%
References
147
Citations per year

Authors

2

Topics & keywords

Keywords
  • ERBB3
  • Receptor tyrosine kinase
  • ErbB
  • Tyrosine kinase
  • Receptor
  • ERBB4
  • Cancer research
  • Epidermal growth factor receptor
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.

Funding